Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02762253 · ClinicalTrials.gov registry record · Phase 2
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
A Phase 2 study, sponsored by Nvision Laser Eye Centers.
- Terminated
- Registry status
- Phase 2
- Development phase
- 320
- Enrollment target
NCT02762253 is a Phase 2 study that was terminated before completion, run by Nvision Laser Eye Centers. The registered enrollment target is 320 participants.
The verdict
NCT02762253, a Phase 2 study, was terminated before completion, sponsored by Nvision Laser Eye Centers.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 320 participants
- Enrollment target
Study Summary
This study is being conducted to assess the safety and effectiveness of photochemically induced collagen cross- linking (CCL) at irradiance of 18mW/cm2 in eyes with Keratoconus and Ecstasia.
Interventions
- DRUG Riboflavin drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02762253
The ClinicalTrials.gov registry entry for NCT02762253 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nvision Laser Eye Centers, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Riboflavin drops is the first listed.
NCT02762253 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02762253 about?
NCT02762253 is a clinical study titled "Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.". This study is being conducted to assess the safety and effectiveness of photochemically induced collagen cross- linking (CCL) at irradiance of 18mW/cm2 in eyes with Keratoconus and Ecstasia.
What is the current status of trial NCT02762253?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 320 participants. The study started on 2012-09. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02762253?
The interventions under investigation include: Riboflavin drops (DRUG).
Who is sponsoring clinical trial NCT02762253?
This trial is sponsored by Nvision Laser Eye Centers, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.